PHARMACEUTICAL DISSOLUTION TESTING – Qatar MoPH & USP Compliant Services

Pharmaceutical Dissolution Testing evaluates how rapidly and completely the active pharmaceutical ingredient (API) is released from solid oral dosage forms into a dissolution medium simulating the gastrointestinal environment.

In Qatar’s regulated pharmaceutical market, dissolution testing is essential for demonstrating bioavailability consistency, batch-to-batch reliability, and pharmaceutical equivalence between generic and reference products. It serves as a critical quality control and regulatory tool ensuring that medications dispensed across Qatar’s hospitals and pharmacies perform as intended.

Mets Lab Qatar delivers regulatory-aligned PHARMACEUTICAL DISSOLUTION TESTING in Qatar, supporting product development, batch release, stability studies, and Ministry of Public Health submissions.

Why PHARMACEUTICAL DISSOLUTION TESTING is Critical in Qatar

Ensures Therapeutic Performance

A tablet that does not dissolve properly cannot deliver therapeutic benefit. Dissolution testing confirms:

• Correct drug release rate
• Complete drug availability
• Consistent absorption potential
• Controlled-release profile accuracy

Mandatory for Regulatory Approval

The Qatar Ministry of Public Health requires dissolution data for:

• Product registration
• Generic drug approval
• Biowaiver applications
• Post-approval manufacturing changes
• Batch release authorization

Supports Generic Drug Equivalence

Comparative dissolution profile testing enables demonstration of pharmaceutical equivalence to reference listed drugs, reducing the need for additional in vivo studies.

Protects Patient Outcomes

Improper dissolution may result in:

• Subtherapeutic dosing
• Delayed onset of action
• Dose dumping in modified-release products
• Increased adverse effects

Dissolution testing safeguards medication performance across Qatar’s healthcare system.

Core Dissolution Testing Capabilities

USP Apparatus Portfolio

We operate complete pharmacopeial systems including:

• Apparatus 1 – Rotating Basket
• Apparatus 2 – Paddle
• Apparatus 3 – Reciprocating Cylinder
• Apparatus 4 – Flow-Through Cell

Apparatus selection is scientifically aligned with dosage form characteristics and Qatar regulatory expectations.

Dissolution Media Optimization

Careful control of:

• pH selection
• Buffer composition
• Surfactant levels
• Ionic strength

Media are optimized to create discriminating yet physiologically relevant conditions.

Strategic sampling intervals capture:

• Initial release phase
• Sustained release region
• Complete dissolution endpoint

Specifications are structured according to Qatar MoPH and pharmacopeial guidance.

Integrated Analytical Detection

• UV-Visible Spectrophotometry
• HPLC analysis
• Stability-indicating quantification methods

All analytical procedures are validated per international regulatory standards.

Comparative Profile Analysis

• Similarity factor (f2) calculation
• Difference factor (f1) assessment
• Statistical equivalence evaluation

These tools are critical for generic drug registration submissions in Qatar.

Industries We Serve in Qatar

Advanced Capabilities

Why Choose Mets Lab Qatar for PHARMACEUTICAL DISSOLUTION TESTING?

• Qatar MoPH-aligned methodologies
• USP & EP compliant apparatus systems
• Fully qualified & calibrated instrumentation
• Advanced analytical integration
• Experienced regulatory documentation support
• ISO/IEC 17025 quality management framework

We combine scientific precision with regulatory intelligence to deliver dissolution data that supports product approval, protects patient safety, and enhances pharmaceutical credibility in Qatar and GCC markets.